Sales & Marketing

Why a fundamental rethinking of how manufacturers engage with healthcare providers, payers, and patients is necessary in today's pharma landscape.

Marketing and sales personnel who leverage the expertise and insights of MedAffairs can often have better success.

Addressing key challenges in the modern sales sector requires a fundamental shift in training strategies.

The high-stakes nature of cancer care, coupled with rapid scientific advancements and increasing payer and regulatory pressures, demands a specialized approach beyond traditional market access strategies.

The two organizations will work together to promote healthy choices, such as early screenings.

Applying the McKinsey 7S Framework to TLL and regional marketing teams.

Market dynamics boost the need and urgency for more sophisticated benchmarking strategies.

eHealth’s latest survey reveals Americans give the nation’s healthcare system a low grade and are open to significant changes.

Heather Gervais, CEO of Osso VR, discusses how technological advancements in VR are solving problems for pharmaceutical sales reps.

March is Colorectal Cancer Awareness Month, and the health plan hopes to improve survival rates with early screenings.

A monthly roundup of business and people news in the pharmaceutical industry.

The actor is leading a campaign focused on joint pain.

Anonymous reports claim the decision came from new leadership at HHS.

Traditional approaches to HCP segmentation are no longer sufficient. The challenge now is to maintain personalization at scale while managing large territories and diverse customer bases.

The campaign is based on the results of a survey that reveals the experiences of patients and caregivers in their communities.

The Blitz the Barriers initiative aims to reduce disparities among prostate cancer patients.

In this Q&A, Organon's Chief Communications Officer, Becky Edwards discusses how much social media and influencers sway decisions about birth control methods, potential consequences of these misinformed choices, and more.

How one Big Pharma ad campaign is incorporating diversity as a driving force in improving the ways drugs are marketed directly to the patients that need them.

The benefits for brand teams in bolstering their rapid-response capability.

In this part of his Pharmaceutical Executive video interview, Ian Baer, Founder & CEO of Sooth, explores the contributing factors growing distrust and uncertainty surrounding social media.

Biljana Naumovic discusses the importance of finding ways to reach out to underserved communites.

Biljana Naumovic of Johnson & Johnson discusses the unique fashion show and how it's raising awareness for prostate cancer.

A Harvard Business School Healthcare Alumni Association Q&A with Paul Ollinger, one of Facebook’s first 250 employees.

With increasing cases of disinformation across social media blurring the lines of what’s credible and real, how can pharma break through the noise and build back public trust?

These professionals in the healthcare marketing sector have been chosen by their peers for making big moves and taking on larger roles.

In this part of her Pharmaceutical Executive video interview, Angela Tenuta, President, Full Service Agencies, at EVERSANA INTOUCH, shares some best practices for pharma companies to ensure their messaging resonates across different cultures and healthcare systems.

In this Pharmaceutical Executive video interview, Angela Tenuta, President, Full Service Agencies, at EVERSANA INTOUCH, provides examples of how pharmaceutical companies are working to address equitable access to medicines in low- and middle-income countries.

Industry voices stress importance of a strategic approach to social media marketing, choosing platforms wisely, prioritize privacy, leveraging targeted advertising techniques and more.

A look at the promise and opportunities from this new and advanced type of AI in transforming commercial planning and execution for life sciences companies.

In this part of her Pharmaceutical Executive video interview, Angela Tenuta, President, Full Service Agencies, at EVERSANA INTOUCH, elaborates on the challenges and strategies for fostering collaboration between different industry groups and pharma companies for the Direct-to-Patient model.